Minimizing Weapons-Usable Nuclear Material: A Nuclear Security Success Story Still in Progress
One of the most significant achievements in reducing the risk of nuclear terrorism over the past two decades is something that rarely makes headlines.
Risky Business
Welcome to the blog
Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Get To Know NTI: Amanda Krieger
Humidity, Hard Truths, and the Future of Global Health Security
A Simple Step to Close a Dangerous Biosecurity Gap
Three Strikes: Why Giving Up on the NPT Is Not an Option
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
Humidity, Hard Truths, and the Future of Global Health Security
Multisectoral collaboration is a fundamental requirement for stronger health security.
A Simple Step to Close a Dangerous Biosecurity Gap
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
AIxBio Horizon Scan Finds Accelerating Capabilities Require Urgent Oversight
The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.
Why Responsible AIxBio Innovation Must Be on New Delhi’s Agenda
Some of the world’s largest AI companies—Google DeepMind, OpenAI, and Anthropic—have warned that their models could be misused to cause harm with biology. The India AI Impact Summit is a critical moment for policymakers, scientists, developers, and biosecurity experts to work together on responsible governance that reduces AIxBio risks.
AIxBio = Big Promise + New Risks
The AI-biology convergence offers enormous benefits but also brings about risks as we’ve never seen before. Without action from multiple disciplines, the race for AI development and dominance could become a race to the bottom when it comes to safety and security.
Congress Must Act to Secure U.S. Biotechnology
Innovation requires security, and security requires innovation. Congress needs to act decisively to ensure U.S. leadership in biotechnology is paired with governance that keeps its development secure.
Improving Biosecurity through Metadata Capture
As the capabilities of biological AI tools continue to advance at an accelerating pace, it is vital that DNA synthesis providers and others in the biosecurity space embrace new guardrails to prevent their misuse.
Strengthening Trust in Bioscience Research & Development
Over the past decade, governments, private industry, and academic institutions have increased their investments in bioscience research and development, yielding global benefits. However, these advancements have also increased the risk of deliberate misuse of biology to cause harm.
ChatGPT Agent Setting Industry Leading Example for Biosecurity Safeguards
OpenAI's latest release, ChatGPT Agent, represents a significant leap forward in artificial intelligence capabilities—and with it comes a thoughtful, proactive approach to managing the biosecurity risks that advanced AI systems can pose.
What is Biosecurity — Explained
Since the emergence of the term in the late 20th century, “biosecurity” has had a wide variety of meanings. While biosecurity is fundamental to the work of NTI | bio, we have not explicitly laid out our definition of biosecurity — until now.
Risky Business is edited by:
Scott Nolan Smith
Senior Director, Communications
Mary Olney Fulham
Director, Communications